Improvement in brain oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride.
D000368:Aged; D001783:Blood Flow Velocity; D001921:Brain / Q000378:metabolism; D002245:Carbon Dioxide; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010092:Oximetry; D010101:Oxygen Consumption; D010208:Papaverine / Q000009:adverse effects / Q000627:therapeutic use*
D002245:Carbon Dioxide; D010208:Papaverine